The UK government is to double emergency supplies of flu drugs to treat everyone who is predicted to fall ill in a pandemic. Contracts awarded to Roche and GlaxoSmithKline will double anti- viral stockpiles, which are expected to be in place by April. An addi- tional 7.6 million treatment courses of Tamiflu (oseltamivir, Roche) and 10.6m treatment courses of Relenza (zanamivir, GlaxoSmithKline) will be delivered, bringing the total number of antiviral treatment courses to 33.5m.
展开▼